Pre-exposure prophylaxis (PrEP) was conceived to fill the urgent need for a woman-controlled HIV prevention method. However, biomedical technology alone will not alter the underlying gender inequalities that make women and girls vulnerable to HIV. This technical brief was developed by Michele Lanham from FHI360 – an OPTIONS consortium partner. It focuses on addressing gender while ensuring effective PrEP introduction.

Amaqhawekazi Harm Reduction Summit 2026 Communique
NACOSA hosted the Amaqhawekazi Harm Reduction Summit 2026, from 26-27 August 2026, bringing together representatives of government departments, civil society organisations, community-led organisations, development partners, researchers, advocates, people who use


